Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael M Lederman

Showing results (141-150 of 303) with videos related to

Pageof 31
Sort By:
AIDS (London, England)|November 2, 2005
Differential effect of interleukin-2 treatment on primary and secondary immunizations in HIV infected individualsHaydar Kuekrek, Tobias Schlingmann, Hernan Valdez, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 4, 2016
Brief Report: CD14brightCD16- monocytes and sCD14 level negatively associate with CD4-memory T-cell frequency and predict HCV-decline on therapyChelsey J Judge, Johan K Sandberg, Nicholas T Funderburg, et al.
Journal of Clinical Lipidology|April 11, 2017
Effects of atorvastatin on biomarkers of immune activation, inflammation, and lipids in virologically suppressed, human immunodeficiency virus-1-infected individuals with low-density lipoprotein cholesterol <130 mg/dL (AIDS Clinical Trials Group Study A5275)Daniel E Nixon, Ronald J Bosch, Ellen S Chan, et al.
AIDS (London, England)|August 9, 2021
Plasma galectin-9 as a predictor of adverse non-AIDS events in persons with chronic HIV during suppressive antiretroviral therapyThomas A Premeaux, Carlee B Moser, Ashley McKhann, et al.
Blood|February 10, 2007
Abnormal activation and cytokine spectra in lymph nodes of people chronically infected with HIV-1Angélique Biancotto, Jean-Charles Grivel, Sarah J Iglehart, et al.
International Journal of Cardiology|July 27, 2013
Perivascular fat, inflammation, and cardiovascular risk in HIV-infected patients on antiretroviral therapyChris T Longenecker, Ying Jiang, Chun-Ho Yun, et al.
AIDS (London, England)|April 3, 2014
Soluble CD14 is independently associated with coronary calcification and extent of subclinical vascular disease in treated HIV infectionChris T Longenecker, Ying Jiang, Carl E Orringer, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 5, 2012
HIV-1 is not a major driver of increased plasma IL-6 levels in chronic HIV-1 diseaseCarey L Shive, Angélique Biancotto, Nicholas T Funderburg, et al.
Journal of the National Cancer Institute|May 16, 2002
Therapeutic challenges of AIDS-related non-Hodgkin's lymphoma in the United States and East AfricaMwanda W Otieno, Cecily Banura, Edward Katongole-Mbidde, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 28, 2011
Disease-modifying therapeutic concepts for HIV in the era of highly active antiretroviral therapyScott L Butler, Hernan Valdez, Michael Westby, et al.
Pageof 31

Showing results (141-150 of 303) with videos related to

Sort By:
Pageof 31
AIDS (London, England)|November 2, 2005
Differential effect of interleukin-2 treatment on primary and secondary immunizations in HIV infected individualsHaydar Kuekrek, Tobias Schlingmann, Hernan Valdez, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 4, 2016
Brief Report: CD14brightCD16- monocytes and sCD14 level negatively associate with CD4-memory T-cell frequency and predict HCV-decline on therapyChelsey J Judge, Johan K Sandberg, Nicholas T Funderburg, et al.
Journal of Clinical Lipidology|April 11, 2017
Effects of atorvastatin on biomarkers of immune activation, inflammation, and lipids in virologically suppressed, human immunodeficiency virus-1-infected individuals with low-density lipoprotein cholesterol <130 mg/dL (AIDS Clinical Trials Group Study A5275)Daniel E Nixon, Ronald J Bosch, Ellen S Chan, et al.
AIDS (London, England)|August 9, 2021
Plasma galectin-9 as a predictor of adverse non-AIDS events in persons with chronic HIV during suppressive antiretroviral therapyThomas A Premeaux, Carlee B Moser, Ashley McKhann, et al.
Blood|February 10, 2007
Abnormal activation and cytokine spectra in lymph nodes of people chronically infected with HIV-1Angélique Biancotto, Jean-Charles Grivel, Sarah J Iglehart, et al.
International Journal of Cardiology|July 27, 2013
Perivascular fat, inflammation, and cardiovascular risk in HIV-infected patients on antiretroviral therapyChris T Longenecker, Ying Jiang, Chun-Ho Yun, et al.
AIDS (London, England)|April 3, 2014
Soluble CD14 is independently associated with coronary calcification and extent of subclinical vascular disease in treated HIV infectionChris T Longenecker, Ying Jiang, Carl E Orringer, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 5, 2012
HIV-1 is not a major driver of increased plasma IL-6 levels in chronic HIV-1 diseaseCarey L Shive, Angélique Biancotto, Nicholas T Funderburg, et al.
Journal of the National Cancer Institute|May 16, 2002
Therapeutic challenges of AIDS-related non-Hodgkin's lymphoma in the United States and East AfricaMwanda W Otieno, Cecily Banura, Edward Katongole-Mbidde, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 28, 2011
Disease-modifying therapeutic concepts for HIV in the era of highly active antiretroviral therapyScott L Butler, Hernan Valdez, Michael Westby, et al.
Pageof 31